| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA806524 | F | Percent of growth inhibition of Cell line SW962 (Vulvar) by the compound | Homo sapiens | 3 | ALA1132376 | cell-based format | Scientific Literature | |
| 2. | ALA806697 | F | Percent of growth inhibition of Cell line SW962 (Vulvar) by the compound | Homo sapiens | 2 | ALA1132376 | cell-based format | Scientific Literature | |
| 3. | ALA806698 | F | Percentage efficacy for Beta RARE transactivation in SW962 cells | Homo sapiens | 5 | ALA1134528 | cell-based format | Scientific Literature | |
| 4. | ALA806699 | F | Percentage efficacy for Beta RARE transactivation in SW962 cells | Homo sapiens | 1 | ALA1134528 | cell-based format | Scientific Literature | |
| 5. | ALA806700 | F | Potency against beta RARE transactivation in SW962 cells | Homo sapiens | 6 | ALA1134528 | cell-based format | Scientific Literature | |
| 6. | ALA2363696 | F | SANGER: Inhibition of human SW962 cell growth in a cell viability assay. | Homo sapiens | 137 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer |
The page will load shortly, Thanks for your patience!